Why the study?
Does a customized polypill improve adherence to quadruple guideline-directed medical therapy in adults with HFrEF compared to individual tablets?
Does a customized polypill improve adherence to quadruple guideline-directed medical therapy in adults with HFrEF compared to individual tablets?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Recent advances, such as automated over-encapsulation and pharmaceutical 3D printing, could increase the potential of this strategy to be brought to scale.”
A customizable polypill delivering quadruple guideline-directed medical therapy for HFrEF is feasible, highly acceptable, and significantly improves short-term medication adherence compared to individual tablets.
No abstract yet. The journal hasn't published one we can show.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
DeJong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: